Skip to main content
SpringerLink
Log in

Against

  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gjedde A, Reith J, Dyve S, Dicksic M, Evans AC, Kuwabara H. DOPA decarboxylase activity of the living human brain. Proc Natl Acad Sci U S A 1991; 88:2721–2725.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 2001; 28:266–272.

    Article  CAS  PubMed  Google Scholar 

  3. Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson’s disease and normal aging. Ann Neurol 1996; 40:873–884.

    Article  CAS  PubMed  Google Scholar 

  4. Vander Borght TM, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 1996; 294:577–583.

    Article  Google Scholar 

  5. Tedroff J, Ekesbo A, Rydin E, Långström B, Hagberg G. Regulation of dopaminergic activity in early Parkinson’s disease. Ann Neurol 1999; 46:359–365.

    Article  CAS  PubMed  Google Scholar 

  6. Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease. Ann Neurol 2000; 47:493–503.

    Article  CAS  PubMed  Google Scholar 

  7. Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, Brucke T. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration Mov Disord 2000; 15:1158–1167.

    Article  CAS  PubMed  Google Scholar 

  8. Parkinson Study Group. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Neurology 2000; 55:1540–1547.

    Article  Google Scholar 

  9. Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink MH, Sips HJ, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, Lees AJ, Costa DC, Gacinovic S, Oertel WH, Pogarell O, Hoeffken H, Joseph K, Tatsch K, Schwarz J, Ries V. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000; 15:503–510.

    Article  CAS  PubMed  Google Scholar 

  10. Albin RL, Koeppe RA, Chervin RD, Consens FB, Wernette K, Frey KA, Aldrich MS. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000; 55:1410–1412.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Radiology (Division of Nuclear Medicine) and Neurology, The University of Michigan, Room B1G-412, AGH, 1500 East Medical Center Drive, Ann Arbor, MI, 48109-0028, USA

    Kirk A. Frey

Authors
  1. Kirk A. Frey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kirk A. Frey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frey, K.A. Against. Eur J Nucl Med 29, 715–717 (2002). https://doi.org/10.1007/s00259-002-0815-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-002-0815-4

Keywords

Search

Navigation